Inozyme Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021	2016 - 2020
Net Income	4,092	4,331	3,972	3,826	5,231	Upgrade
Depreciation & Amortization	4,264	4,287	4,176	3,970	3,793	Upgrade
Asset Writedown & Restructuring Costs	64	183	140	53	102	Upgrade
Stock-Based Compensation	154	163	182	190	200	Upgrade
Provision & Write-off of Bad Debts	521	421	696	403	577	Upgrade
Other Operating Activities	2,641	2,358	2,822	4,509	2,104	Upgrade
Change in Accounts Receivable	-1,780	-270	782	-310	-1,389	Upgrade
Change in Accounts Payable	-2,445	-2,553	-3,331	-1,861	71	Upgrade
Change in Other Net Operating Assets	-475	-608	-591	-948	-554	Upgrade
Operating Cash Flow	7,036	8,312	8,848	9,832	10,135	Upgrade
Operating Cash Flow Growth	-15.35%	-6.06%	-10.01%	-2.99%	98.84%	Upgrade
Capital Expenditures	-4,055	-5,176	-6,174	-6,763	-5,884	Upgrade
Sale of Property, Plant & Equipment	115	114	84	94	102	Upgrade
Cash Acquisitions	-	-	-	-	-228	Upgrade
Investment in Securities	-152	-138	-84	-147	-	Upgrade
Investing Cash Flow	-4,092	-5,200	-6,174	-6,816	-6,010	Upgrade
Long-Term Debt Issued	-	-	-	-	4,212	Upgrade
Long-Term Debt Repaid	-157	-147	-152	-161	-6,318	Upgrade
Net Debt Issued (Repaid)	-157	-147	-152	-161	-2,106	Upgrade
Issuance of Common Stock	524	491	231	184	740	Upgrade
Repurchase of Common Stock	-3,017	-2,500	-1,500	-2,248	-	Upgrade
Common Dividends Paid	-1,339	-1,259	-1,177	-793	-686	Upgrade
Other Financing Activities	-30	-11	1	-1	-38	Upgrade
Financing Cash Flow	-4,019	-3,426	-2,597	-3,019	-2,090	Upgrade
Foreign Exchange Rate Adjustments	76	-41	-118	-187	171	Upgrade
Net Cash Flow	-999	-355	-41	-190	2,206	Upgrade
Free Cash Flow	2,981	3,136	2,674	3,069	4,251	Upgrade
Free Cash Flow Growth	-4.94%	17.28%	-12.87%	-27.81%	-	Upgrade
Free Cash Flow Margin	3.39%	3.58%	2.97%	3.28%	5.06%	Upgrade
Free Cash Flow Per Share	12.27	12.49	10.45	11.54	15.86	Upgrade
Cash Interest Paid	814	744	694	695	819	Upgrade
Cash Income Tax Paid	1,250	1,433	1,043	177	1,319	Upgrade
Levered Free Cash Flow	3,495	2,737	3,082	1,058	3,531	Upgrade
Unlevered Free Cash Flow	3,988	3,203	3,516	1,488	4,027	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.